Tech Company Financing Transactions
Cognate BioServices Funding Round
Cognate BioServices closed a Series B funding round on 1/29/2020. Investors included EW Healthcare Partners and Medivate Partners.
Transaction Overview
Company Name
Announced On
1/29/2020
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
EW Healthcare Partners (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4600 East Shelby Dr. 108
Memphis, TN 38118
USA
Memphis, TN 38118
USA
Phone
Website
Email Address
Not Recorded
Overview
Cognate BioServices is a leading contract development and manufacturing organization specialized in cell and cell-mediated gene therapies. We pride ourselves in the level of quality and experience we bring to the table.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kelly Ganjei
Chief Financial Officer
William James
Vice President
Karim Khoury
Vice President
Lori Noffsinger
VP - Bus. Development
Michael Stella
VP - Finance
Jaehyung Yoon
VP - General Counsel
Shari Piré
VP - Human Resources
Roy Cohen
VP - Manufacturing
Scott Law
VP - Regulatory Affairs
Margaret Owens
VP - Sales
Scott Broughton
Browse more venture capital transactions:
Prev: 1/29/2020: AppOmni venture capital transaction
Next: 1/29/2020: Aumni venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs